Literature DB >> 27402918

Endothelial Restoration of Receptor Activity-Modifying Protein 2 Is Sufficient to Rescue Lethality, but Survivors Develop Dilated Cardiomyopathy.

Daniel O Kechele1, William P Dunworth1, Claire E Trincot1, Sarah E Wetzel-Strong1, Manyu Li1, Hong Ma1, Jiandong Liu1, Kathleen M Caron2.   

Abstract

RAMPs (receptor activity-modifying proteins) serve as oligomeric modulators for numerous G-protein-coupled receptors, yet elucidating the physiological relevance of these interactions remains complex. Ramp2 null mice are embryonic lethal, with cardiovascular developmental defects similar to those observed in mice null for canonical adrenomedullin/calcitonin receptor-like receptor signaling. We aimed to genetically rescue the Ramp2(-/-) lethality in order to further delineate the spatiotemporal requirements for RAMP2 function during development and thereby enable the elucidation of an expanded repertoire of RAMP2 functions with family B G-protein-coupled receptors in adult homeostasis. Endothelial-specific expression of Ramp2 under the VE-cadherin promoter resulted in the partial rescue of Ramp2(-/-) mice, demonstrating that endothelial expression of Ramp2 is necessary and sufficient for survival. The surviving Ramp2(-/-) Tg animals lived to adulthood and developed spontaneous hypotension and dilated cardiomyopathy, which was not observed in adult mice lacking calcitonin receptor-like receptor. Yet, the hearts of Ramp2(-/-) Tg animals displayed dysregulation of family B G-protein-coupled receptors, including parathyroid hormone and glucagon receptors, as well as their downstream signaling pathways. These data suggest a functional requirement for RAMP2 in the modulation of additional G-protein-coupled receptor pathways in vivo, which is critical for sustained cardiovascular homeostasis. The cardiovascular importance of RAMP2 extends beyond the endothelium and canonical adrenomedullin/calcitonin receptor-like receptor signaling, in which future studies could elucidate novel and pharmacologically tractable pathways for treating cardiovascular diseases.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  G-protein–coupled receptor; calcitonin receptor-like receptor; cardiomyopathy, dilated; endothelium; hypotensionreceptor activity–modifying protein

Mesh:

Substances:

Year:  2016        PMID: 27402918      PMCID: PMC4982823          DOI: 10.1161/HYPERTENSIONAHA.116.07191

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  50 in total

1.  The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity.

Authors:  Yuka Ichikawa-Shindo; Takayuki Sakurai; Akiko Kamiyoshi; Hisaka Kawate; Nobuyoshi Iinuma; Takahiro Yoshizawa; Teruhide Koyama; Junichi Fukuchi; Satoshi Iimuro; Nobuo Moriyama; Hayato Kawakami; Toshinori Murata; Kenji Kangawa; Ryozo Nagai; Takayuki Shindo
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 2.  Understanding RAMPs through genetically engineered mouse models.

Authors:  Mahita Kadmiel; Kimberly L Fritz-Six; Kathleen M Caron
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

3.  Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure.

Authors:  M Nakamura; H Yoshida; S Makita; N Arakawa; H Niinuma; K Hiramori
Journal:  Circulation       Date:  1997-03-04       Impact factor: 29.690

4.  Glucagon stimulates the cardiac Ca2+ current by activation of adenylyl cyclase and inhibition of phosphodiesterase.

Authors:  P F Méry; V Brechler; C Pavoine; F Pecker; R Fischmeister
Journal:  Nature       Date:  1990-05-10       Impact factor: 49.962

5.  Cardiac-specific overexpression of dominant-negative CREB leads to increased mortality and mitochondrial dysfunction in female mice.

Authors:  Peter A Watson; Nicholas Birdsey; Gordon S Huggins; Eric Svensson; Daniel Heppe; Leslie Knaub
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-08       Impact factor: 4.733

6.  Calcium-sensing receptor-dependent activation of CREB phosphorylation in HEK293 cells and human parathyroid cells.

Authors:  Vimesh A Avlani; Wenting Ma; Hee-Chang Mun; Katie Leach; Leigh Delbridge; Arthur Christopoulos; Arthur D Conigrave
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-26       Impact factor: 4.310

7.  Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart.

Authors:  R C Fentzke; C E Korcarz; R M Lang; H Lin; J M Leiden
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

8.  Protection of angiotensin II-induced vascular hypertrophy in vascular smooth muscle-targeted receptor activity-modifying protein 2 transgenic mice.

Authors:  Lihuan Liang; Christina W Tam; Gabor Pozsgai; Richard Siow; Natalie Clark; Julie Keeble; Knut Husmann; Walter Born; Jan A Fischer; Robin Poston; Ajay Shah; Susan D Brain
Journal:  Hypertension       Date:  2009-10-26       Impact factor: 10.190

9.  Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males.

Authors:  Kathleen Caron; John Hagaman; Toshio Nishikimi; Hyung-Suk Kim; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

10.  Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2).

Authors:  Cathryn Weston; Jing Lu; Naichang Li; Kerry Barkan; Gareth O Richards; David J Roberts; Timothy M Skerry; David Poyner; Meenakshi Pardamwar; Christopher A Reynolds; Simon J Dowell; Gary B Willars; Graham Ladds
Journal:  J Biol Chem       Date:  2015-07-21       Impact factor: 5.157

View more
  9 in total

1.  Adrenomedullin Induces Cardiac Lymphangiogenesis After Myocardial Infarction and Regulates Cardiac Edema Via Connexin 43.

Authors:  Claire E Trincot; Wenjing Xu; Hua Zhang; Molly R Kulikauskas; Thomas G Caranasos; Brian C Jensen; Amélie Sabine; Tatiana V Petrova; Kathleen M Caron
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

2.  Amylin Selectively Signals Onto POMC Neurons in the Arcuate Nucleus of the Hypothalamus.

Authors:  Thomas A Lutz; Bernd Coester; Lynda Whiting; Ambrose A Dunn-Meynell; Christina N Boyle; Sebastien G Bouret; Barry E Levin; Christelle Le Foll
Journal:  Diabetes       Date:  2018-02-21       Impact factor: 9.461

3.  VE-Cadherin Is Required for Cardiac Lymphatic Maintenance and Signaling.

Authors:  Natalie R Harris; Natalie R Nielsen; John B Pawlak; Amir Aghajanian; Krsna Rangarajan; D Stephen Serafin; Gregory Farber; Danielle M Dy; Nathan P Nelson-Maney; Wenjing Xu; Disha Ratra; Sophia H Hurr; Li Qian; Joshua P Scallan; Kathleen M Caron
Journal:  Circ Res       Date:  2021-11-18       Impact factor: 17.367

4.  Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.

Authors:  J B Pawlak; S E Wetzel-Strong; M K Dunn; K M Caron
Journal:  Peptides       Date:  2016-12-08       Impact factor: 3.750

5.  A murine model of increased coronary sinus pressure induces myocardial edema with cardiac lymphatic dilation and fibrosis.

Authors:  Natalie R Nielsen; Krsna V Rangarajan; Lan Mao; Howard A Rockman; Kathleen M Caron
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-06       Impact factor: 4.733

6.  hCALCRL mutation causes autosomal recessive nonimmune hydrops fetalis with lymphatic dysplasia.

Authors:  Duncan I Mackie; Fuad Al Mutairi; Reema B Davis; Daniel O Kechele; Natalie R Nielsen; Joshua C Snyder; Marc G Caron; Harvey J Kliman; Jonathan S Berg; John Simms; David R Poyner; Kathleen M Caron
Journal:  J Exp Med       Date:  2018-08-16       Impact factor: 17.579

Review 7.  Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.

Authors:  Ramiro Vázquez; Maria E Riveiro; Caroline Berenguer-Daizé; Anthony O'Kane; Julie Gormley; Olivier Touzelet; Keyvan Rezai; Mohamed Bekradda; L'Houcine Ouafik
Journal:  Front Oncol       Date:  2021-01-06       Impact factor: 6.244

Review 8.  Fetal nuchal edema and developmental anomalies caused by gene mutations in mice.

Authors:  Akira Sugiyama; Masanori Hirashima
Journal:  Front Cell Dev Biol       Date:  2022-08-30

9.  Loss of receptor activity-modifying protein 2 in mice causes placental dysfunction and alters PTH1R regulation.

Authors:  Mahita Kadmiel; Brooke C Matson; Scott T Espenschied; Patricia M Lenhart; Kathleen M Caron
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.